查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1701285

藥物發現資訊學市場規模、佔有率、趨勢分析報告：按服務、應用、最終用途、地區、細分市場預測，2025-2030 年

Drug Discovery Informatics Market Size, Share & Trends Analysis Report By Service (Molecular Modelling), By Application (Discovery Informatics), By End-use (Academic & Research Institutes), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

藥物發現資訊學市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球藥物發現資訊學市場預計到2030年將達到70.3億美元，2025年至2030年的複合年成長率為11.6%。

由於快速的藥物設計和合成、有效追蹤疾病進展和資料完整性管理等多種優勢，近年來，研究人員使用藥物發現軟體獲取市場情報的情況顯著增加，從而推動了該行業的成長。

對新型分子的需求不斷成長，推動了資訊學解決方案的採用，旨在透過目標大分子相互作用來識別合理的藥物分子，從而加快整個藥物發現過程。在市場上營運的公司正在獲得資金來擴大其藥物發現平台，進一步推動市場成長。例如，2020年9月，Ardigen與國家研究發展中心簽署協議，獲得新技術開發的資金。

該技術旨在徹底改變基於 T 細胞受體的免疫腫瘤治療方法的發展。先前，ArdImmune Vax 開發了一個新抗原預測平台，部署了即用型人工智慧 (AI) 和生物資訊解決方案，以確定最佳新抗原作為過繼性細胞療法和癌症疫苗的標靶。此外，化學資訊學解決方案在過去一年中獲得了顯著的發展，特別是在滿足與最近的 COVID-19 大流行相關的需求方面。

例如，2021年1月進行的一項研究展示了透過對SARS-CoV主蛋白酶（Mpro）抑制劑的歷史活性資料進行資料分析，應用化學數位解決方案來加速SARS-CoV-2 Mpro抑製劑的發現。此外，QSAR 模型有助於分子資料探勘，從而快速發現 COVID-19 藥物。因此，加快 COVID-19 藥物開發的需求預計將在未來幾年推動產業擴張。

藥物發現資訊學市場報告重點

  • 序列分析平台將主導市場，到 2024 年將佔據 36.4% 的最大收益佔有率。生物資訊解決方案被廣泛用於開發核酸、蛋白質和其他生物分子序列的一級和二級資料庫。
  • 2024 年，藥物發現資訊學領域將佔最大收入佔有率，約 60.2%，主要專注於精準醫療開發。精準醫療的核心是提供根據個人基因和分子特徵量身定做的個人化醫療。
  • 製藥和生物技術公司將主導市場，到 2024 年將獲得 48.4% 的最大收益佔有率。這一成長是由研發支出的增加所推動的，尤其是在精準醫療領域。
  • 由於主要市場參與者的存在和完善的研發基礎設施，北美在 2024 年引領全球市場。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章藥物發現資訊學市場變數、趨勢和範圍

  • 市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境分析
    • 產業分析-波特五力分析
    • PESTLE分析

第4章藥物發現資訊學市場：按服務分類的業務分析

  • 2024 年及 2030 年各服務市場佔有率
  • 服務細分細分儀表板
  • 市場規模、預測與趨勢分析（按服務，2018-2030 年）
  • 序列分析平台
  • 分子建模
  • 對接
  • 臨床試驗資料管理
  • 其他

第5章藥物發現資訊學市場：按應用進行的業務分析

  • 2024 年及 2030 年各應用領域的市場佔有率
  • 應用程式細分儀表板
  • 市場規模、預測與趨勢分析（按應用，2018-2030 年）
  • 藥物發現資訊學
  • 生物內容管理

第6章藥物發現資訊學市場：最終使用者的業務分析

  • 2024 年和 2030 年按最終用途分類的市場佔有率
  • 最終用途細分儀表板
  • 按最終用途分類的市場規模、預測和趨勢分析（2018-2030 年）
  • 製藥和生物技術公司
  • CRO 和 CMO
  • 學術研究所

第7章藥物發現資訊學市場：區域估計與趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 市場規模、預測趨勢分析，2018 年至 2030 年：
  • 北美洲
    • 2018-2030年各國情況
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018-2030年各國情況
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030年各國情況
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 2018-2030年各國情況
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 2018-2030年各國情況
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章競爭格局

  • 參與者概述
  • 企業市場分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/列表
    • Certara
    • Boehringer Ingelheim International GmbH
    • Infosys Ltd.
    • Charles River Laboratories
    • Collaborative Drug Discovery, Inc.
    • Eurofins DiscoverX Products
    • Jubliant Biosys
    • Selvita
    • Novo Informatics Pvt. Ltd.
    • ChemAxon Ltd.
    • Albany Molecular Research Inc.
    • Oracle
    • Accenture
    • Agilent Technologies, Inc.
    • Illumina, Inc.
Product Code: 978-1-68038-749-0

Drug Discovery Informatics Market Growth & Trends:

The global drug discovery informatics market size is expected to reach USD 7.03 billion by 2030, registering a CAGR of 11.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. Use of drug discovery software for gaining market intelligence owing to several advantages, such as rapid drug design & synthesis, efficient tracking of disease evolution, and data integrity management, has increased significantly among the researchers in the recent years, driving the industry growth.

The growing demand for novel molecules is driving the adoption of informatics solutions targeted towards speeding up the entire drug discovery process by identifying rational drug molecules via the target macromolecule interaction. Companies operating in the market are receiving funding for expanding their drug discovery platforms, further supplementing the market growth. For instance, in September 2020, Ardigen signed an agreement with the National Centre for Research and Development to access its funding for developing novel technology.

This technology was aimed at revolutionizing the development of T-cell receptors-based therapies for immuno-oncology. Ardigen has previously developed a neoantigen prediction platform namely, ArdImmune Vax, which deploys ready-to-use Artificial Intelligence (AI) and bioinformatics solutions for the identification of optimal sets of neoantigens as targets for adoptive cell therapies and cancer vaccines. In addition, chemical informatics solutions have gained considerable traction in the past year, particularly in addressing the needs associated with the recent Covid-19 pandemic.

For instance, a research study performed in January 2021 showcased the application of chemical digital solutions in accelerating the search of SARS-CoV-2 Mpro inhibitors by data analysis of previous activity data of SARS-CoV main protease (Mpro) inhibitors. In addition, the QSAR models helped in the data mining of molecules for rapid Covid-19 drug discovery. Hence, the need to facilitate drug development for Covid-19 is expected to propel the industry expansion over the coming years.

Drug Discovery Informatics Market Report Highlights:

  • The sequence analysis platforms dominated the market and accounted for the largest revenue share of 36.4% in 2024. Bioinformatics solutions are widely employed for the development of primary and secondary databases of nucleic acids, proteins, and other biomolecule sequences.
  • The discovery informatics segment accounted for the largest revenue share of around 60.2% in 2024, with a major focus on developing precision medicines. Precision medicine revolves around providing personalized medical care tailored to an individual's genetic and molecular profile.
  • Pharmaceutical and biotechnology companies held the dominant position in the market, with the largest revenue share of 48.4% in 2024. This growth is attributed to increased R&D spending, particularly in precision medicine.
  • North America led the global market in 2024 due to the presence of key market players and established R&D infrastructure in the country

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Drug Discovery Informatics Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Drug Discovery Informatics Market: Service Business Analysis

  • 4.1. Service Market Share, 2024 & 2030
  • 4.2. Service Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Service, 2018 to 2030 (USD Million)
  • 4.4. Sequence Analysis Platforms
    • 4.4.1. Sequence Analysis Platforms Market, 2018 - 2030 (USD Million)
  • 4.5. Molecular Modelling
    • 4.5.1. Molecular Modelling Market, 2018 - 2030 (USD Million)
  • 4.6. Docking
    • 4.6.1. Docking Market, 2018 - 2030 (USD Million)
  • 4.7. Clinical Trial Data Management
    • 4.7.1. Clinical Trial Data Management Market, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Drug Discovery Informatics Market: Application Business Analysis

  • 5.1. Application Market Share, 2024 & 2030
  • 5.2. Application Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Discovery Informatics
    • 5.4.1. Discovery Informatics Market, 2018 - 2030 (USD Million)
  • 5.5. Biocontent Management
    • 5.5.1. Biocontent Management Market, 2018 - 2030 (USD Million)

Chapter 6. Drug Discovery Informatics Market: End Use Business Analysis

  • 6.1. End Use Market Share, 2024 & 2030
  • 6.2. End Use Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 6.5. CROs & CMOs
    • 6.5.1. CROs & CMOs Market, 2018 - 2030 (USD Million)
  • 6.6. Academic & Research Institutes
    • 6.6.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)

Chapter 7. Drug Discovery Informatics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Drug Discovery Informatics Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Drug Discovery Informatics Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Denmark Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Sweden Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Norway Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Drug Discovery Informatics Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. Australia Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Thailand Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. South Korea
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. South Korea Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Drug Discovery Informatics Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Drug Discovery Informatics Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Certara
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Boehringer Ingelheim International GmbH
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Infosys Ltd.
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Charles River Laboratories
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Collaborative Drug Discovery, Inc.
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Eurofins DiscoverX Products
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Jubliant Biosys
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Selvita
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Novo Informatics Pvt. Ltd.
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. ChemAxon Ltd.
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives
    • 8.5.11. Albany Molecular Research Inc.
      • 8.5.11.1. Overview
      • 8.5.11.2. Financial Performance
      • 8.5.11.3. Product Benchmarking
      • 8.5.11.4. Strategic Initiatives
    • 8.5.12. Oracle
      • 8.5.12.1. Overview
      • 8.5.12.2. Financial Performance
      • 8.5.12.3. Product Benchmarking
      • 8.5.12.4. Strategic Initiatives
    • 8.5.13. Accenture
      • 8.5.13.1. Overview
      • 8.5.13.2. Financial Performance
      • 8.5.13.3. Product Benchmarking
      • 8.5.13.4. Strategic Initiatives
    • 8.5.14. Agilent Technologies, Inc.
      • 8.5.14.1. Overview
      • 8.5.14.2. Financial Performance
      • 8.5.14.3. Product Benchmarking
      • 8.5.14.4. Strategic Initiatives
    • 8.5.15. Illumina, Inc.
      • 8.5.15.1. Overview
      • 8.5.15.2. Financial Performance
      • 8.5.15.3. Product Benchmarking
      • 8.5.15.4. Strategic Initiatives

List of Tables

  • Table 1. List Of Secondary Sources
  • Table 2. List Of Abbreviations
  • Table 3. Global Drug Discovery Informatics Market, By Region, 2018 - 2030 (USD Million)
  • Table 4. Global Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 5. Global Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 6. Global Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 7. North America Drug Discovery Informatics Market, By Country, 2018 - 2030 (USD Million)
  • Table 8. North America Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 9. North America Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 10. North America Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 11. U.S. Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 12. U.S. Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 13. U.S. Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 14. Canada Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 15. Canada Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 16. Canada Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 17. Mexico Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 18. Mexico Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 19. Mexico Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 20. Europe Drug Discovery Informatics Market, By Country, 2018 - 2030 (USD Million)
  • Table 21. Europe Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 22. Europe Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 23. Europe Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 24. UK Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 25. UK Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 26. UK Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 27. Germany Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 28. Germany Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 29. Germany Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 30. France Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 31. France Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 32. France Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 33. Italy Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 34. Italy Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 35. Italy Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 36. Spain Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 37. Spain Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 38. Spain Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 39. Denmark Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 40. Denmark Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 41. Denmark Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 42. Sweden Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 43. Sweden Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 44. Sweden Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 45. Norway Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 46. Norway Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 47. Norway Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 48. Asia Pacific Drug Discovery Informatics Market, By Country, 2018 - 2030 (USD Million)
  • Table 49. Asia Pacific Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 50. Asia Pacific Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 51. Asia Pacific Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 52. Japan Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 53. Japan Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 54. Japan Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 55. China Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 56. China Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 57. China Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 58. India Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 59. India Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 60. India Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 61. Australia Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 62. Australia Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 63. Australia Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 64. Thailand Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 65. Thailand Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 66. Thailand Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 67. South Korea Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 68. South Korea Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 69. South Korea Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 70. Latin America Drug Discovery Informatics Market, By Country, 2018 - 2030 (USD Million)
  • Table 71. Latin America Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 72. Latin America Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 73. Latin America Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 74. Brazil Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 75. Brazil Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 76. Brazil Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 77. Argentina Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 78. Argentina Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 79. Argentina Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 80. Middle East & Africa Drug Discovery Informatics Market, By Country, 2018 - 2030 (USD Million)
  • Table 81. Middle East & Africa Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 82. Middle East & Africa Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 83. Middle East & Africa Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 84. South Africa Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 85. South Africa Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 86. South Africa Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 87. Saudi Arabia Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 88. Saudi Arabia Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 89. Saudi Arabia Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 90. UAE Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 91. UAE Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 92. UAE Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 93. Kuwait Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
  • Table 94. Kuwait Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
  • Table 95. Kuwait Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Drug Discovery Informatics Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Data Triangulation Techniques
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 Market Formulation & Validation
  • Fig. 8 Market Snapshot
  • Fig. 9 Service and Application Outlook (USD Million)
  • Fig. 10 End Use Outlook (USD Million)
  • Fig. 11 Competitive Landscape
  • Fig. 12 Drug Discovery Informatics Market Dynamics
  • Fig. 13 Drug Discovery Informatics Market: Porter's Five Forces Analysis
  • Fig. 14 Drug Discovery Informatics Market: PESTLE Analysis
  • Fig. 15 Drug Discovery Informatics Market: Service Segment Dashboard
  • Fig. 16 Drug Discovery Informatics Market: Service Market Share Analysis, 2024 & 2030
  • Fig. 17 Sequence Analysis Platforms Market, 2018 - 2030 (USD Million)
  • Fig. 18 Molecular Modelling Market, 2018 - 2030 (USD Million)
  • Fig. 19 Docking Market, 2018 - 2030 (USD Million)
  • Fig. 20 Clinical Trial Data Management Market, 2018 - 2030 (USD Million)
  • Fig. 21 Others Market, 2018 - 2030 (USD Million)
  • Fig. 22 Drug Discovery Informatics Market: Application Segment Dashboard
  • Fig. 23 Drug Discovery Informatics Market: Application Market Share Analysis, 2024 & 2030
  • Fig. 24 Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 25 Biocontent Management Market, 2018 - 2030 (USD Million)
  • Fig. 26 Drug Discovery Informatics Market: End Use Segment Dashboard
  • Fig. 27 Drug Discovery Informatics Market: End Use Market Share Analysis, 2024 & 2030
  • Fig. 28 Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • Fig. 29 CROs & CMOs Market, 2018 - 2030 (USD Million)
  • Fig. 30 Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • Fig. 31 Drug Discovery Informatics Market Revenue, By Region
  • Fig. 32 Regional Marketplace: Key Takeaways
  • Fig. 33 Regional Marketplace: Key Takeaways
  • Fig. 34 North America Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. Country Dynamics
  • Fig. 36 U.S. Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 37 Canada Country Dynamics
  • Fig. 38 Canada Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 39 Mexico Country Dynamics
  • Fig. 40 Mexico Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 41 Europe Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 42 UK Country Dynamics
  • Fig. 43 UK Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 44 Germany Country Dynamics
  • Fig. 45 Germany Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 46 France Country Dynamics
  • Fig. 47 France Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 48 Italy Country Dynamics
  • Fig. 49 Italy Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 50 Spain Country Dynamics
  • Fig. 51 Spain Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 52 Norway Country Dynamics
  • Fig. 53 Norway Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 54 Sweden Country Dynamics
  • Fig. 55 Sweden Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 56 Denmark Country Dynamics
  • Fig. 57 Denmark Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 58 Asia Pacific Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 59 Japan Country Dynamics
  • Fig. 60 Japan Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 61 China Country Dynamics
  • Fig. 62 China Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 63 India Country Dynamics
  • Fig. 64 India Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 65 Australia Country Dynamics
  • Fig. 66 Australia Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 67 Thailand Country Dynamics
  • Fig. 68 Thailand Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 69 South Korea Country Dynamics
  • Fig. 70 South Korea Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 71 Latin America Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 72 Brazil Country Dynamics
  • Fig. 73 Brazil Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 74 Argentina Country Dynamics
  • Fig. 75 Argentina Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 76 MEA Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 77 South Africa Country Dynamics
  • Fig. 78 South Africa Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 79 Saudi Arabia Country Dynamics
  • Fig. 80 Saudi Arabia Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 81 UAE Country Dynamics
  • Fig. 82 UAE Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 83 Kuwait Country Dynamics
  • Fig. 84 Kuwait Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
  • Fig. 85 Company Categorization
  • Fig. 86 Company Market Position Analysis
  • Fig. 87 Strategic Framework